What You Should Know:
– Teladoc Health, Inc. has announced a significant change in its executive leadership structure. Laizer Kornwasser, President of Enterprise Growth and Global Markets, has been terminated without cause as part of a reorganization of the company’s executive reporting structure. This change will take effect on July 1, 2024.
– Mr. Kornwasser, who has been with Teladoc since October 24, 2022, will remain with the company in an advisory capacity to the Chief Executive Officer until August 2, 2024. During this transitional period, he will assist with the leadership transition and ensure continuity in the company’s operations.
– Under the terms of his Executive Employment Agreement, Mr. Kornwasser will receive the payments and benefits outlined in his contract. This agreement was established when he joined Teladoc Health, reflecting his significant contributions to the company’s growth and global market expansion.
– The decision to restructure the executive reporting framework is part of Teladoc Health’s ongoing strategy to streamline operations and enhance its focus on delivering innovative virtual care solutions. The company remains committed to its mission of transforming how people access and experience healthcare worldwide.
